Poullac Pharmaceuticals Private Limited
About Poullac Pharmaceuticals Private Limited
Data last updated:
Poullac Pharmaceuticals Private Limited is a private limited company based in Saharanpur, Uttar Pradesh, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 09 March 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24232UP2005PTC029587. Its GSTIN is 09AADCP5524C1ZN (Uttar Pradesh).
The company has an authorised share capital of ₹18.5 Lakh and a paid-up capital of ₹18.5 Lakh. It is led by directors Shitij Gumber and Nitin Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 5 Industrial Estat Delhi Road, Saharanpur, Uttar Pradesh, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.25 Lakh, a decline of 77% compared to the previous year. For the same year it recorded a net loss of ₹6.5 Lakh (net margin -24.8%) and EBITDA of -₹4.3 Lakh (EBITDA margin -16.4%). Revenue has declined at a compounded annual rate (CAGR) of 44% over three years and 16% over five years.
As per MCA filings, the company has open charges of ₹32 Lakh and satisfied charges of ₹16 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Poullac Pharmaceuticals Private Limited's registered office is in Saharanpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressE – 5 Industrial Estat Delhi Road, Saharanpur, Uttar Pradesh, India
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Poullac Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Poullac Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Poullac Pharmaceuticals Private Limited, buy the company report.
Financials of Poullac Pharmaceuticals Private Limited
FY 2025 filings availablePoullac Pharmaceuticals Private Limited reported revenue of ₹26.25 Lakh (down 77% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 16% over five years, including a 77% fall in the latest year. EBITDA fell 79% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹4.3 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -16.4% | ||||
| Net Profit Margin | -24.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Poullac Pharmaceuticals Private Limited, buy the company report.
Board of directors of Poullac Pharmaceuticals Private Limited
Poullac Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shitij Gumber | Director | 30 Jan 2009 | 17 Years 9 Months | Current |
| Nitin Kumar | Director | 30 Jan 2009 | 17 Years 9 Months | Current |
Auditor
Poullac Pharmaceuticals Private Limited is audited by G.S. CHUGH & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G.S. CHUGH & ASSOCIATES | FY 2017 | 008884C |
Shareholding
The shareholding of Poullac Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Poullac Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Feb 2014 | 10519094 | Punjab & Sind Bank | ₹27 Lakh | Open | |
| 31 Oct 2005 | 80060359 | Sbi | ₹5 Lakh | Open | |
| 31 Oct 2005 | 80060360 | State Bank of India | ₹16 Lakh | Satisfied |
To see the full charge records of Poullac Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Poullac Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
| High courts | 1 | 1 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Allahabad High Court | Court case (A482) | Filed against the company | Pending |
| District court, Central, Delhi | Criminal case | Filed against the company by Keshav Himchem Pvt Ltd | Disposed |
To see the full case history of Poullac Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Poullac Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Poullac Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCP5524C1ZN | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Poullac Pharmaceuticals Private Limited, buy the company report.
Recent activity
Poullac Pharmaceuticals Private Limited has 5 board changes on record since 2009: 2 appointments and 3 cessations. The latest: Bharat Bhushan ceased to be Director on 05 May 2019.
1 earlier event is in the company report.
Frequently asked questions
Poullac Pharmaceuticals is an active private limited company based in Saharanpur, Uttar Pradesh, India. The company works in chemical products, within the chemicals industry. It was incorporated on 09 March 2005 (21+ years old) and is registered under CIN U24232UP2005PTC029587.
Poullac Pharmaceuticals has 2 current directors:
- Shitij Gumber - Director
- Nitin Kumar - Director
The latest financial statements of Poullac Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Poullac Pharmaceuticals is 09AADCP5524C1ZN, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Poullac Pharmaceuticals is U24232UP2005PTC029587. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Poullac Pharmaceuticals has 2 court cases on record: 2 filed against it. 1 is pending. Most are in the district courts.
Poullac Pharmaceuticals was incorporated on 09 March 2005, making it 21+ years old. It is registered with the Registrar of Companies, Kanpur.
Bharat Bhushan ceased to be Director on 05 May 2019. Pramod Kumar ceased to be Director on 02 Apr 2009. Vinod Gumber ceased to be Director on 02 Apr 2009. Poullac Pharmaceuticals has 5 board changes on record in total.
The registered office of Poullac Pharmaceuticals is at E – 5 Industrial Estat Delhi Road, Saharanpur, Uttar Pradesh, India.
Poullac Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
